The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more

RAG rating
n/a
Document type
Decision document
Place
South and West Hertfordshire
Output type
Pharmacy / Prescribing
Clinical Pathways
Pathway
Medication Overuse Headache Pathway

Medication Overuse Headache


Pathway Publish Date: October 2024
Pathway Next Review Date: October 2026
 
  Medication overuse headache:
    • Headache occurring on 15 or more days per month in a person with a pre-existing primary headache disorder, which develops as a consequence of regular overuse of one or more drugs that can be taken for acute and/or symptomatic treatment of headache, for more than 3 months. It usually, but not always, resolves after the overused medication is stopped.
    • Ergotamines, triptans, opioids, or combination analgesics are taken on 10 days or more per month.
    • Simple analgesics such as paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs), or aspirin (either alone or in any combination) are taken on 15 days or more per month.
  • Medication overuse headache is a chronic headache disorder, and the pre-existing primary headache is migraine in 60–80% of people, or more rarely tension-type headache.
    • Medication overuse headache is generally of the same phenotype as the primary headache.

  • Complications may include stress, anxiety, depression, sleep disturbance, and an increased risk of transition from episodic to chronic migraine if untreated.
  • Most people with medication overuse headache improve after withdrawal of overused medication.


 
Please see pathway attached for further information 
Back